Cargando…
Algorithm to improve the diagnosis of paraneoplastic neurological syndromes associated with SOX1 antibodies
SOX1 antibodies (SOX1-abs) are associated with paraneoplastic neurological syndromes (PNS) and small cell lung cancer (SCLC). In many clinical laboratories SOX1-abs are determined by commercial line blots without confirmation by cell-based assay (CBA) with HEK293 cells expressing SOX1. However, the...
Autores principales: | Arnaldos-Pérez, Cristina, Vilaseca, Andreu, Naranjo, Laura, Sabater, Lidia, Dalmau, Josep, Ruiz-García, Raquel, Graus, Francesc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191251/ https://www.ncbi.nlm.nih.gov/pubmed/37207233 http://dx.doi.org/10.3389/fimmu.2023.1173484 |
Ejemplares similares
-
Caveats and Pitfalls of SOX1 Autoantibody Testing With a Commercial Line Blot Assay in Paraneoplastic Neurological Investigations
por: Ruiz-García, Raquel, et al.
Publicado: (2019) -
Antibody Repertoire in Paraneoplastic Cerebellar Degeneration and Small Cell Lung Cancer
por: Sabater, Lidia, et al.
Publicado: (2013) -
The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders
por: Maddison, Paul, et al.
Publicado: (2019) -
Paraneoplastic cerebellar ataxia and antibodies to metabotropic glutamate receptor 2
por: Ruiz-García, Raquel, et al.
Publicado: (2019) -
Limitations of a Commercial Assay as Diagnostic Test of Autoimmune Encephalitis
por: Ruiz-García, Raquel, et al.
Publicado: (2021)